Morristown, NJ, United States of America

Mahdi Bakir Fawzi

USPTO Granted Patents = 32 

 


Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 524(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mahdi Bakir Fawzi

Introduction

Mahdi Bakir Fawzi, based in Morristown, New Jersey, is a prolific inventor with an impressive portfolio of 31 patents. His work primarily focuses on advancements in pharmaceutical compositions, reflecting his dedication to enhancing drug formulations and delivery methods.

Latest Patents

Among his latest innovations are two notable patents concerning tigecycline compositions and methods of preparation. These inventions relate to novel tigecycline compositions that boast improved stability in both solid and solution states. The compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer, showcasing Mahdi's commitment to developing more effective pharmaceutical products.

Career Highlights

Throughout his career, Mahdi Bakir Fawzi has significantly contributed to the pharmaceutical industry by working with renowned companies such as Wyeth and American Cyanamid Company. His experience in these organizations has undoubtedly provided him with a robust foundation for his inventive endeavors.

Collaborations

Collaboration appears to be a pivotal aspect of Mahdi’s career. He has worked alongside talented individuals such as Syed Muzafar Shah and Tianmin Zhu. These partnerships not only highlight his ability to work in teams but also enrich the innovative process through diverse expertise.

Conclusion

Mahdi Bakir Fawzi stands out as an influential figure in the field of pharmaceuticals with his substantial number of patents and collaborative spirit. His work on tigecycline compositions exemplifies the importance of innovation in improving drug stability and efficacy, reinforcing his status as a key contributor to medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…